Sagimet Biosciences, Inc. Class A (SGMT) Stock Statistics & Valuation Metrics

Sagimet Biosciences, Inc. Class A has a market cap or net worth of $73.01M. The enterprise value is -$6.29M.

Sagimet Biosciences, Inc. Class A has 30.67M shares outstanding. The number of shares has decreased by -2.65% in one year.

Sagimet Biosciences, Inc. Class A’s return on equity (ROE) is -0.29 and return on invested capital (ROIC) is -34.93%.

The current PE Ratio of Sagimet Biosciences, Inc. Class A is -3.10. Sagimet Biosciences, Inc. Class A’s PEG ratio is 0.07.

In the last 12 months, Sagimet Biosciences, Inc. Class A had revenue of $0.00 and earned -$37.52M in profits. Earnings per share was -$1.38.

In the last 12 months, operating cash flow was -$38.49M and capital expenditures $0.00, giving a free cash flow of -$38.49M billion.

Sagimet Biosciences, Inc. Class A pays an annual dividend of , resulting in a dividend yield of

Sagimet Biosciences, Inc. Class A upcoming earnings date is May 14, 2025, Before Open.

Sagimet Biosciences, Inc. Class A as a current ratio of 34.30, with Debt / Equity ratio of <0.01

In the past 12 months, Sagimet Biosciences, Inc. Class A has paid -$10.08M in taxes.

Sagimet Biosciences, Inc. Class A EV to EBITDA ratio is -1.20, with an EV/FCF ratio of -1.54.

Sagimet Biosciences, Inc. Class A has $152.49M in cash and marketable securities with $116.00K in debt, giving a net cash position of -$152.37M billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Sagimet Biosciences, Inc. Class A is $32.50, which is 11.43% higher than the current price. The consensus rating is Strong Buy